Yipinhong Pharmaceutical Co Ltd banner

Yipinhong Pharmaceutical Co Ltd
SZSE:300723

Watchlist Manager
Yipinhong Pharmaceutical Co Ltd Logo
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Watchlist
Price: 39.82 CNY 2.87%
Market Cap: ¥18B

Yipinhong Pharmaceutical Co Ltd
Tax Provision

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Yipinhong Pharmaceutical Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Tax Provision
¥95.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Tax Provision
-¥995.1m
CAGR 3-Years
-40%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Tax Provision
-¥1.1B
CAGR 3-Years
-130%
CAGR 5-Years
-13%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Tax Provision
-¥853.3m
CAGR 3-Years
-17%
CAGR 5-Years
8%
CAGR 10-Years
-6%
Zhejiang Nhu Co Ltd
SZSE:002001
Tax Provision
-¥1B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
-28%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Tax Provision
-¥270.6m
CAGR 3-Years
N/A
CAGR 5-Years
-126%
CAGR 10-Years
N/A
No Stocks Found

Yipinhong Pharmaceutical Co Ltd
Glance View

Market Cap
18B CNY
Industry
Pharmaceuticals

Yipinhong Pharmaceutical Co Ltd has carved its niche in the pharmaceutical landscape of China, with its roots embedded deeply in the nation's flourishing healthcare sector. Known for its dedication to combining traditional Chinese medicinal practices with modern scientific research, the company stands out in an increasingly competitive market. Yipinhong's operations are centered around developing, manufacturing, and distributing a broad spectrum of medicinal products that adhere to the highest quality standards. By focusing on therapeutic areas such as respiratory, cardiovascular, and gastrointestinal health, they strategically align with the growing demand for reliable medicinal solutions. What makes Yipinhong truly distinctive is its investment in research and development that drives innovation. This focus not only ensures a continuous pipeline of new products but positions them as a leader in the integration of traditional remedies with cutting-edge pharmaceutical science. The company thrives on a business model that maximizes its robust distribution network, encompassing both domestic and international markets. Yipinhong capitalizes on its vast network of sales agents and partnerships with hospitals, clinics, and pharmacies to ensure its products reach consumers efficiently. This network amplifies their revenue streams by tapping into various segments within the pharmaceutical supply chain. Moreover, Yipinhong's strategic collaborations for research and development and their participation in healthcare industry events bolster their market presence and brand recognition. By maintaining a harmonious balance between traditional approaches and modern demands, Yipinhong not only captures a unique market position but also sets a benchmark in pharmaceutical excellence and innovation.

Intrinsic Value
8.85 CNY
Overvaluation 78%
Intrinsic Value
Price ¥39.82

See Also

What is Yipinhong Pharmaceutical Co Ltd's Tax Provision?
Tax Provision
95.9m CNY

Based on the financial report for Sep 30, 2025, Yipinhong Pharmaceutical Co Ltd's Tax Provision amounts to 95.9m CNY.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett